Evaluation of surgery for Parkinson's disease: A report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology

Neurology

Volumn 53, Issue 9, 1999, Pages 1910-1921

  Hallett, Mark ^a   Litvan, Irene ^a  

^a AMERICAN ACADEMY OF NEUROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL MEDULLA; ARTICLE; BRAIN DEPTH STIMULATION; DATA BASE; FOLLOW UP; GLOBUS PALLIDUS; HUMAN; MAJOR CLINICAL STUDY; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; SURGICAL TECHNIQUE; THALAMOTOMY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0032763526     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.9.1910     Document Type: Article

References (109)

1. Bucy PC, Case JT. Tremor: physiologic mechanism and abolition by surgical means. Arch Neurol Psychiatr 1939;41:721-746.
2. Klemme RM. Surgical treatment of dystonia, paralysis agitans and athetosis. Arch Neurol Psychiatr 1940;44:926.
3. Meyers R. Surgical procedure for postencephalitic tremor, with notes on the physiology of premotor fibres. Arch Neurol Psychiatr 1940;44:455-457.
4. Meyers R. The modification of alternating tremors, rigidity and festination by surgery of the basal ganglia. Proc Assoc Nerv Ment Dis 1942;21:602-665.
5. Spiegel EA, Wycis HT. Ansotomy in paralysis agitans. Arch Neurol Psychiatr 1954;71:598-614.
6. Spiegel EA, Wycis HT, Baird HW. Long-range effects of electropallidodensotomy in extrapyramidal and convulsive disorders. Neurology 1958;8:734-740.
7. Cooper IS. Intracerebral injection of procaine into the globus pallidus in hyperkinetic disorders. Science 1954;119:417-418.
8. Hassler R. The pathological and pathophysiological basis of tremor and parkinsonism. Second International Congress of Neuropathology, Excerpta Medica Foundation. Amsterdam: Excerpta Medica, 1955:29-40.
9. Hassler R. The influence of stimulations and coagulations in the human thalamus on the tremor at rest and its physiopathologic mechanism. Second International Congress of Neuropathology, Excerpta Medica Foundation. Amsterdam: Excerpta Medica, 1955:637-642.
10. Narabayashi H, Ohye C. Parkinsonian tremor and nucleus ventralis intermedius of the human thalamus. In: Desmedt JE, ed. Physiological tremor. Pathological tremors and clonus. Basel: S. Karger, 1978:165-172.
11. Narabayashi H. Surgical approach to tremor. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworth Scientific, 1982:292-299.
12. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-639.
13. Spencer DD, Robbins RJ, Naftolin F, et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 1992;327:1541-1548.
14. Dogali ME, Fazzini E, Kolodny E, et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-761.
15. Wester K, Hauglie-Hanssen E. Stereotaxic thalamotomy-experiences from the levodopa era. J Neurol Neurosurg Psychiatry 1990;53:427-430.
16. Fox MW, Ahlskog JE, Kelly PJ. Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients. J Neurosurg 1991; 75:723-730.
17. Diederich N, Goetz CG, Stebbins GT, et al. Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease. Neurology 1992;42:1311-1314.
18. Jankovic J, Cardoso F, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery 1995;37:680-687.
19. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
20. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-1387.
21. Baron MS, Vitek JL, Bakay RAE, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996;40:355-366.
22. Fazzini E, Dogali M, Sterio D, Eidelberg D, Beric A. Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy. Neurology 1997;48:1273-1277.
23. Hariz MI, De Salles AA. The side-effects and complications of posteroventral pallidotomy. Acta Neurochir Suppl (Wien) 1997;68:42-48.
24. Kazumata K, Antonini A, Dhawan V, et al. Preoperative indicators of clinical outcome following stereotaxic pallidotomy. Neurology 1997;49:1083-1090.
25. Kishore A, Turnbull IM, Snow BJ, et al. Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations. Brain 1997;120:729-737.
26. Krauss JK, Desaloms JM, Lai EC, King DE, Jankovic J, Grossman RG. Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis. J Neurosurg 1997;87: 358-367.
27. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997;337:1036-1042.
28. Soukup VM, Ingram F, Schiess MC, Bonnen JG, Nauta HJ, Calverley JR. Cognitive sequelae of unilateral posteroventral pallidotomy. Arch Neurol 1997;54:947-950.
29. Uitti RJ, Wharen RE Jr, Turk MF, et al. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology 1997;49:1072-1077.
30. Biousse V, Newman NJ, Carroll C, et al. Visual fields in patients with posterior GPi pallidotomy. Neurology 1998;50: 258-265.
31. Giller CA, Dewey RB, Ginsburg MI, Mendelsohn DB, Berk AM. Stereotactic pallidotomy and thalamotomy using individual variations of anatomic landmarks for localization. Neurosurgery 1998;42:56-62; discussion 62-55.
32. Ondo WG, Jankovic J, Lai EC, et al. Assessment of motor function after stereotactic pallidotomy. Neurology 1998;50: 266-270.
33. Shannon KM, Penn RD, Kroin JS, et al. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients. Neurology 1998;50:434-438.
34. Scott R, Gregory R, Hines N, et al. Neuropsychological, neurological, and functional outcome following pallidotomy for Parkinson's disease: a consecutive series of eight simultaneous and twelve unilateral procedures. Brain 1998;121: 659-675.
35. Samuel M, Caputo E, Brooks DJ, et al. A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. Brain 1998;121:59-75.
36. Lozano AM, Lang AE, Hutchison WD. Pallidotomy for tremor. Mov Disord 1998;13:107-110.
37. Masterman D, DeSalles A, Baloh RW, et al. Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson disease. Arch Neurol 1998;55: 1201-1208.
38. Cahn DA, Sullivan EV, Shear PK, et al. Neuropsychological and motor functioning after unilateral anatomically guided posterior ventral pallidotomy. Preoperative performance and three-month follow-up. Neuropsychiatr Neuropsychol Behav Neurol 1998;11:136-145.
39. Trepanier LL, Saint-Cyr JA, Lozano AM, Lang AE. Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease. Neurology 1998;51: 207-215.
40. Benabid AL, Pollack P, Hommel M, Gaio JM, De Rougemont J, Perret J. Treatment of Parkinson tremor by chronic stimulation of the ventral intermediate nucleus of the thalamus. Rev Neurol Paris 1989;145:320-323.
41. Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403-406.
42. Blond S, Siegfried J. Thalamic stimulation for the treatment of tremor and other movement disorders. Acta Neurochir Suppl 1991;52(suppl):109-111.
43. Blond S, Caparros-Lefebvre D, Parker F, et al. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 1992;77:62-68.
44. Deiber MP, Pollak P, Passingham R, et al. Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography. Brain 1993;116:267-279.
45. Caparros-Lefebvre D, Ruchoux MM, Blond S, Petit H, Percheron G. Long-term thalamic stimulation in Parkinson's disease: postmortem anatomoclinical study. Neurology 1994; 44:1856-1860.
46. Alesch F, Pinter MM, Helscher RJ, Fertl L, Benabid AL, Koos WT. Stimulation of the ventral intermediate thalamic nucleus in tremor dominant Parkinson's disease and essential tremor. Acta Neurochir 1995;136:75-81.
47. Benabid AL, Pollak P, Seigneuret E, Hoffmann D, Gay E, Perret J. Chronic Vim thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl 1993;58(suppl):39-44.
48. Caparros-Lefebvre D, Blond S, Vermersch P, Pecheux N, Guieu JD, Petit H. Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993;56:268-273.
49. Speelman JD, Bosch DA. Continuous electric thalamus stimulation for the treatment of tremor resistant to pharmacotherapy. Ned Tijdschr Geneeskd 1995;139:926-930.
50. Benabid AL, Pollak P, Gao DM, et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996;84:203-214.
51. Koller W, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997;42:292-299.
52. Benabid AL, Blond S, Pollak P, Caparros-Lefebvre D. Electrical neuroinhibition of CMPf is effective on tremor and L-DOPA induced dyskinesia in Parkinson's disease. Neurology 1997;48:A357. Abstract.
53. Geny C, Nguyen JP, Pollin B, et al. Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation. Mov Disord 1996;11:489-494.
54. Tasker RR. Deep brain stimulation is preferable to thalamotomy for tremor suppression. Surg Neurol 1998;49:145-153; discussion 153-154.
55. Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology 1998:51:1063-1069.
56. Pahwa R, Wilkinson S, Smith D, Lyons K, Miyawaki E, Koller WC. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. Neurology 1997;49: 249-253.
57. Siegfried J, Lippitz B. Chronic electrical stimulation of the VL-VPL complex and of the pallidum in the treatment of movement disorders: personal experience since 1982. Stereotact Funct Neurosurg 1994;62:71-75.
58. Gross C, Rougier A, Guehl D. High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases. J Neurosurg 1997;87:491-498.
59. Siegfried J, Wellis G. Chronic electrostimulation of ventro-posterolateral pallidum: follow-up. Acta Neurochir Suppl (Wien) 1997;68:11-13.
60. Troster A, Fields J, Wilkinson S, et al. Unilateral pallidal stimulation for Parkinson's disease. Neurology 1997;49: 1078-1083.
61. Krack P, Pollak P, Limousin P, et al. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol 1998;43:180-192.
62. Krack P, Pollak P, Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998;121:451-457.
63. Ghika J, Villemure JG, Fankhauser H, Favre J, Assal G, Ghika-Schmid F. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. J Neurosurg 1998;89:713-718.
64. Galvez-Jimenez N, Lozano A, Tasker R, Duff J, Hutchison W, Lang AE. Pallidal stimulation in Parkinson's disease patients with a prior unilateral pallidotomy. Can J Neurol Sci 1998;25:300-305.
65. Bejjani B, Damier P, Arnulf I, et al. Pallidal stimulation for Parkinson's disease. Two targets? Neurology 1997;49:1564-1569.
66. Limousin P, Pollak P, Benazzouz A, et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95.
67. Pollak P, Benabid AL, Limousin P, et al. Subthalamic nucleus stimulation alleviates akinesia and rigidity in parkinsonian patients. Adv Neurol 1996;69:591-594.
68. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-855.
69. Krack P, Benazzouz A, Pollak P, et al. Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord 1998;13:907-914.
70. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-1111.
71. Ostrosky-Solis F, Quintanar L, Madrazo I, Drucker-Colin R, Franco-Bourland R, Leon-Meza V. Neuropsychological effects of brain autograft of adrenal medullary tissue for the treatment of Parkinson's disease. Neurology 1988;38:1442-1450.
72. Goetz CG, Olanow CW, Koller WC, et al. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med 1989;320:337-341.
73. Lopez-Lozano JJ, Abascal J, Bravo G. A year follow-up of autoimplants of perfused adrenal medulla into parkinsonian patients. Clinica Puerta de Hierro Neural Transplantation Group. Progr Brain Res 1990;82:657-663.
74. Ahlskog JE, Kelly PJ, van Heerden JA, et al. Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies. Mayo Clin Proc 1990;65:305-328.
75. Lopez-Lozano JJ, Bravo G, Abascal J. Grafting of perfused adrenal medullary tissue into the caudate nucleus of patients with Parkinson's disease. Clinica Puerta de Hierro Neural Transplantation Group. J Neurosurg 1991;75:234-243.
76. Goetz CG, Stebbins GT, Klawans HL, et al. United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up. Neurology 1991;41:1719-1722.
77. Waxman MJ, Morantz RA, Koller WC, Paone DB, Nelson PW. High incidence of cardiopulmonary complications associated with implantation of adrenal medullary tissue into the caudate nucleus in patients with advanced neurologic disease. Crit Care Med 1991;19:181-186.
78. Shults CW, O'Connor DT, Baird A, et al. Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid. Exp Neurol 1991;111:276-281.
79. Waters CH, Apuzzo MLJ, Neal JH, Weiner LP. Long-term follow-up of adrenal medullary transplantation for Parkinson's disease. J Geriatr Psychiatry Neurol 1992;5:35-39.
80. Lindvall O, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989;46:615-631.
81. Freed CR, Breeze RE, Rosenberg NL, et al. Fetal neural implants for Parkinson's disease: results at six months and one year. Eur J Pharmacol 1990;183:940-941.
82. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons in Parkinson's disease. Science 1990;247:574-577.
83. Henderson BTH, Clough CG, Hughes RC, Hitchcock ER, Kenny BG. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch Neurol 1991;48:822-827.
84. Lindvall O, Widner H, Rehncrona S, et al. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 1992;31:155-165.
85. Freed CR, Breeze RE, Rosenberg NL, et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 1992;327:1549-1555.
86. Hoffer BJ, Leenders KL, Young D, et al. Eighteen-month course of two patients with grafts of fetal dopamine neurons for severe Parkinson's disease. Exp Neurol 1992;118:243-252
87. Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994;35:172-180.
88. Peschanski M, Defer G, N'Guyen JP, et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994;117:487-499.
89. Freeman TB, Olanow CW, Hauser RA, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995;38:379-388.
90. 18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 1995;38:580-588.
91. Price LH, Spencer DD, Marek KL, et al. Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's disease. Biol Psychiatry 1995;38:498-505.
92. Sass KJ, Buchanan CP, Westerveld M, et al. General cognitive ability following unilateral and bilateral fetal ventral mesencephalic tissue transplantation for treatment of Parkinson's disease. Arch Neurol 1995;52:680-686.
93. Kordower JH, Freeman TB, Snow BJ, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995;332:1118-1124.
94. Defer GL, Geny C, Ricolfi F, et al. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 1996;119:41-50.
95. Lopez-Lozano JJ, Bravo G, Brera B, et al. Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group. J Neurosurg 1997;86:931-942.
96. Wenning GK, Odin P, Morrish P, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997;42:95-107.
97. Tasker RR, Siqueira J, Hawrylshyn PA, Organ LW. What happened to Vim thalamotomy for Parkinson's disease? Appl Neurophysiol 1983;46:68-83.
98. Narabayashi H. Surgical treatment in the levodopa era. In: Stern G, ed. Parkinson's disease. London: Chapman & Hall, 1990:597-646.
99. Young RF, Vermeulen S, Posewitz A, Shumway-Cook A. Pallidotomy with the gamma knife: a positive experience. Stereotact Funct Neurosurg 1998;70(suppl 1):218-228.
100. Friedman JH, Epstein M, Sanes JN, et al. Gamma knife pallidotomy in advanced Parkinson's disease. Ann Neurol 1996;39:535-538.
101. Bonnen JG, Iacono RP, Lulu B, Mohamed AS, Gonzalez A, Schoonenberg T. Gamma knife pallidotomy: case report. Acta Neurochir 1997;139:442-445.
102. Hubble JP, Busenbark KL, Wilkinson S, et al. Effects of thalamic deep brain stimulation based on tremor type and diagnosis. Mov Disord 1997;12:337-341.
103. Tasker RR, Munz M, Junn FS, et al. Deep brain stimulation and thalamotomy for tremor compared. Acta Neurochir Suppl (Wien) 1997;68:49-53.
104. Hariz GM, Bergenheim AT, Hariz MI, Lindberg M. Assessment of ability/disability in patients treated with chronic thalamic stimulation for tremor. Mov Disord 1998;13:78-83.
105. Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 1994;35:1126-1130.
106. Gill SS, Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. Lancet 1997;350:1224.
107. Watts RL, Subramanian T, Freeman A, Goetz CG, Penn RD. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease. Exp Neurol 1997;147:510-517.
108. Kordower JH, Freeman TB, Chen EY, et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 1998;13:383-393.
109. Lopez-Lozano JJ, Bravo G, Brera B, et al. Long-term follow-up in 10 Parkinson's disease patients subjected to fetal brain grafting into a cavity in the caudate nucleus: the Clinica Puerta de Hierro Experience. Clinica Puerta de Hierro Neural Transplantation Group. Transplant Proc 1995; 27:1395-1400.